*Refresh the page if the below document does not appear.
CDSCO suggests Zydus Pharma to conduct Phase II CT for Hepatitis E Vaccine
The SEC under CDSCO has advised Zydus Pharma to conduct its Phase II CT of recombinant Hepatitis E Vaccine (Adsorbed) in volunteers aged 16-25 years along with the Phase I clinical trial report.
Pfizer begins late stage trial of new flu vaccine
One of the first such studies for mRNA based flu shot, the company announced on Wednesday that it has begun a late-stage US trial involving 25,000 patients.
Pharma industry gazing at 30-40 bps hit on renewed NLEM
The updated public rundown of NLEM declared by the government might actually shave off somewhere in the range of 30 and 40 basis points of the Indian Pharmaceutical Market (IPM).
Macleods defers launch of its big-bang IPO
The company IPO (Initial Public Offer) was scheduled to be one of the biggest ever in Pharma Industry. The step was taken by Macleods post the valuation mismatch after discussion with investors, thereby showing the present challenging stock market environment.
Ferring Pharma and FOGSI launches "For Every Mother in India Initiative"
Ferring Pharma launched this new call to action with FOGSI on Tuesday, at the Embassy of Switzerland in New Delhi, to end preventable maternal deaths in India.
Pharmaexcil aims export of $27 Billion in FY 2022-23
Apex Pharma sector body “Pharmaceuticals Export Council of India” stated that Indian Pharma sector clocked exports of US $24.6 Billion in the financial year 2021-22 and US $27.4 billion in exports are their target for the current fiscal year.
ICER gives early support for hemophilia gene treatments from BioMarin and CSL
Institute for Clinical and Economic Review
(ICER), in a draft evidence report released on
Tuesday stated that despite the hefty cost for a
single treatment, oncoming gene therapy is still
the most cost-effective way to treat patients
suffering from Hemophilia types A and B.
